{"organizations": ["Aspen Park Pharmaceuticals"], "uuid": "d848873e9f4a26212e9133f21b0f38dbbce2cb93", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.bio-medicine.org", "main_image": "", "site_section": "http://www.bio-medicine.org/inc/biomed/medicine-technology.asp", "section_title": "Latest Medical Technology from Bio-Medicine.Org", "url": "http://www.bio-medicine.org/medicine-technology-1/Aspen-Park-Pharmaceuticals-acquires-novel-oral-drug-to-treat-castration-resistant-prostate-cancer-48487-1/", "country": "US", "title": "Aspen Park Pharmaceuticals acquires novel oral drug to treat castration resistant prostate cancer", "performance_score": 0, "site": "bio-medicine.org", "participants_count": 0, "title_full": "Aspen Park Pharmaceuticals acquires novel oral drug to treat castration resistant prostate cancer", "spam_score": 0.0, "site_type": "news", "published": "2015-09-30T16:31:00.000+03:00", "replies_count": 0, "uuid": "d848873e9f4a26212e9133f21b0f38dbbce2cb93"}, "author": "", "url": "http://www.bio-medicine.org/medicine-technology-1/Aspen-Park-Pharmaceuticals-acquires-novel-oral-drug-to-treat-castration-resistant-prostate-cancer-48487-1/", "ord_in_thread": 0, "title": "Aspen Park Pharmaceuticals acquires novel oral drug to treat castration resistant prostate cancer", "locations": [], "entities": {"persons": [], "locations": [], "organizations": []}, "highlightText": "", "language": "english", "persons": [], "text": " ", "external_links": [], "published": "2015-09-30T16:31:00.000+03:00", "crawled": "2015-09-30T23:30:31.566+03:00", "highlightTitle": ""}